NCT02713425

Brief Summary

This research study aims to test the feasibility and effectiveness of using an entertaining video game as an addition to traditional therapy for the treatment of anxiety disorders in youth, particularly those youth who may have limited access to mental health treatment in the traditional clinical setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 18, 2016

Completed
7 months until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2017

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

September 4, 2019

Completed
Last Updated

September 4, 2019

Status Verified

August 1, 2019

Enrollment Period

9 months

First QC Date

March 15, 2016

Results QC Date

March 14, 2019

Last Update Submit

August 13, 2019

Conditions

Keywords

AnxietySocial PhobiaSeparation AnxietyGeneralized AnxietyGADPhobiavideo gameteenyouthchildadolescent

Outcome Measures

Primary Outcomes (1)

  • Mean Change From Baseline in Subjective Units of Distress Scale (SUDS) at End of Session

    Subjective Units of Distress Scale (SUDs) - of 0 to 10 ratings, where 0 indicates that they feel no anxiety whatsoever and 10 indicates that they are experiencing maximum distress. The child interacts with the game for up to 30 minutes. The interviewer observes and records the child's interaction with the game. The child then has an opportunity to perform a real life exposure. For the remainder of the time, the interviewer will interview the child about his/her experience with the game. They will also get feedback from the parent.

    approximately 10 minutes

Secondary Outcomes (1)

  • Average Child Rating of Preferring the Game to Not Having the Game

    approximately 30 minutes

Study Arms (1)

Single Arm - Entertaining Video Game

EXPERIMENTAL

The children in this study will have a single visit. During this visit they will be introduced to the game. The child will then interact with the game and after they have finished, they will be asked questions about their experience with the game. Parents will observe and provide their own feedback about the game.

Device: Entertaining Video Game

Interventions

Children between 7 \& 17 with a social anxiety disorder will be invited to participate in this study. They will attend a single visit. During the visit they will use the therapeutic game. They will be monitored while using the game. After the completion, they will be asked questions regarding their experience with this therapeutic game.

Single Arm - Entertaining Video Game

Eligibility Criteria

Age7 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age 7 to 17
  • Primary diagnosis of:
  • social phobia,
  • separation anxiety disorder
  • A parent or other primary care giver available to participate with the child in all assessment and treatment activities
  • Estimated average intelligence
  • English speaking
  • Received les than 3 treatment sessions for social anxiety disorder

You may not qualify if:

  • History of and/or current diagnosis of:
  • psychosis,
  • autism,
  • bipolar disorder,
  • mental retardation,
  • oppositional defiant disorder,
  • PTSD,
  • selective mutism, or
  • major depressive disorder
  • Current suicidality or recent suicidal behavior
  • Parent to be involved in study who is unable to adequately participate due to intellectual or psychiatric difficulties
  • Starting or changing the dosage of a psychiatric medication in the last two months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Anxiety DisordersPhobia, SocialAnxiety, SeparationGeneralized Anxiety DisorderPhobic Disorders

Condition Hierarchy (Ancestors)

Mental DisordersNeurodevelopmental Disorders

Results Point of Contact

Title
Stephen P. Whiteside, PhD, LP
Organization
Mayo Clinic

Study Officials

  • Stephen Whiteside, Ph.D., L.P.

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Psychology

Study Record Dates

First Submitted

March 15, 2016

First Posted

March 18, 2016

Study Start

October 1, 2016

Primary Completion

June 15, 2017

Study Completion

July 15, 2017

Last Updated

September 4, 2019

Results First Posted

September 4, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations